- $7.80bn
- $10.89bn
- $3.48bn
- 84
- 76
- 75
- 93
Annual income statement for Match, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,391 | 2,983 | 3,189 | 3,365 | 3,479 |
| Cost of Revenue | |||||
| Gross Profit | 1,759 | 2,146 | 2,231 | 2,413 | 2,490 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,627 | 2,573 | 2,670 | 2,448 | 2,656 |
| Operating Profit | 764 | 411 | 519 | 917 | 823 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 631 | 256 | 377 | 777 | 704 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 588 | 276 | 362 | 651 | 551 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 162 | 278 | 362 | 652 | 551 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 162 | 278 | 366 | 664 | 564 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.01 | 1.85 | 1.24 | 2.26 | 2.11 |
| Dividends per Share |